Oxandrolone and Abacavir drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Oxandrolone (oxandrolone) and Abacavir (abacavir sulfate). Common drug interactions include abdominal pain among females and blood testosterone decreased among males.

The phase IV clinical study analyzes what interactions people have when they take Oxandrolone and Abacavir. It is created by eHealthMe based on reports of 13 people who take the same drugs from the FDA, and is updated regularly.

What is Oxandrolone?

Oxandrolone has active ingredients of oxandrolone. eHealthMe is studying from 488 Oxandrolone users. Check the latest studies of Oxandrolone.

What is Abacavir?

Abacavir has active ingredients of abacavir sulfate. It is often used in hiv infection. eHealthMe is studying from 8,306 Abacavir users. Check the latest studies of Abacavir.



On Jul, 08, 2026

13 people who take Oxandrolone and Abacavir together, and have interactions are studied.

Oxandrolone and Abacavir drug interactions.

What are the common drug interactions of Oxandrolone and Abacavir, by gender? *:

female:

  1. Abdominal pain
  2. Pyrexia (fever)
  3. Abdominal distension
  4. Abdominal mass (localized enlargement or swelling in the human abdomen)
  5. Adult respiratory distress syndrome (type of lung (pulmonary) failure)
  6. Anaemia (lack of blood)
  7. Anorexia (eating disorder characterized by immoderate food restriction and irrational fear of gaining weight)
  8. Atelectasis (partial or complete collapse of the lung)
  9. Bartonellosis (infectious disease produced by bacteria of the genus bartonella)
  10. Blood albumin decreased

male:

  1. Blood testosterone decreased
  2. Erectile dysfunction
  3. Pancreatitis (inflammation of pancreas)
  4. Tooth loss
  5. Alanine aminotransferase increased
  6. Aspartate aminotransferase increased
  7. Blood amylase increased
  8. Bone density decreased
  9. Death
  10. Drug ineffective

What are the common drug interactions of Oxandrolone and Abacavir, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Abdominal distension
  2. Abdominal mass (localized enlargement or swelling in the human abdomen)
  3. Abdominal pain
  4. Adult respiratory distress syndrome (type of lung (pulmonary) failure)
  5. Anaemia (lack of blood)
  6. Anorexia (eating disorder characterized by immoderate food restriction and irrational fear of gaining weight)
  7. Atelectasis (partial or complete collapse of the lung)
  8. Bartonellosis (infectious disease produced by bacteria of the genus bartonella)
  9. Blood albumin decreased
  10. Blood bicarbonate decreased

30-39:

  1. Blood bilirubin increased
  2. Hepatitis viral

40-49:

  1. Death
  2. Drug ineffective
  3. Fatigue (feeling of tiredness)
  4. Hepatitis b
  5. Hepatitis b antibody positive
  6. Jaundice (a yellowish pigmentation of the skin, the conjunctival membranes)
  7. Nausea (feeling of having an urge to vomit)
  8. Pancreatitis (inflammation of pancreas)
  9. Pulmonary embolism (blockage of the main artery of the lung)
  10. Blood testosterone decreased

50-59:

  1. Blood testosterone decreased
  2. Erectile dysfunction
  3. Sex hormone binding globulin decreased

60+:

n/a

What are the existing conditions these people have? *

  1. Depression: 2 people, 15.38%
  2. Cachexia (loss of weight): 2 people, 15.38%
  3. Pain: 1 person, 7.69%
  4. Neuropathy Peripheral (surface nerve damage): 1 person, 7.69%
  5. Hypogonadism (reduction or absence of hormone secretion or other physiological activity of the gonads (testes or ovaries)): 1 person, 7.69%
  6. Hypertriglyceridaemia (excess of triglycerides in the blood): 1 person, 7.69%
  7. High Blood Pressure: 1 person, 7.69%
  8. Anorexia (eating disorder characterized by immoderate food restriction and irrational fear of gaining weight): 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Oxandrolone and Abacavir?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Oxandrolone and Abacavir:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Oxandrolone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Abacavir:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Oxandrolone and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Abacavir and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on oxandrolone and abacavir sulfate (the active ingredients of Oxandrolone and Abacavir, respectively), and Oxandrolone and Abacavir (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: